Vetoquinol SA Stock price

Equities

VETO

FR0004186856

Pharmaceuticals

Market Closed - Euronext Paris 12:35:25 2024-03-28 pm EDT 5-day change 1st Jan Change
99.5 EUR -0.40% Intraday chart for Vetoquinol SA +1.02% -2.83%
Sales 2023 529M 571M Sales 2024 * 553M 597M Capitalization 1.18B 1.28B
Net income 2023 55M 59.36M Net income 2024 * 56M 60.44M EV / Sales 2023 2.29 x
Net cash position 2023 * 125M 135M Net cash position 2024 * 183M 197M EV / Sales 2024 * 1.81 x
P/E ratio 2023 *
21.5 x
P/E ratio 2024 *
20.7 x
Employees 2,497
Yield 2023 *
0.79%
Yield 2024 *
0.82%
Free-Float 32.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.50%
1 week-1.12%
Current month-3.37%
1 month-3.37%
3 months-4.88%
6 months+26.82%
Current year-4.88%
More quotes
1 week
96.20
Extreme 96.2
102.80
1 month
96.20
Extreme 96.2
106.20
Current year
96.20
Extreme 96.2
110.00
1 year
76.30
Extreme 76.3
110.00
3 years
76.30
Extreme 76.3
161.00
5 years
41.90
Extreme 41.9
161.00
10 years
32.10
Extreme 32.1
161.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01-04-01
Director of Finance/CFO 59 -
Chief Tech/Sci/R&D Officer - 21-02-28
Members of the board TitleAgeSince
Director/Board Member 86 62-07-01
Chief Executive Officer 54 01-04-01
Director/Board Member 83 07-06-03
More insiders
Date Price Change Volume
24-03-28 99.5 -0.40% 4 463
24-03-27 99.9 +0.71% 5,935
24-03-26 99.2 +0.20% 2,637
24-03-25 99 -1.59% 9,818
24-03-22 100.6 +2.13% 4,607

Real-time Euronext Paris, March 28, 2024 at 04:55 am EDT

More quotes
Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets (67.7% of net sales; dogs, cats, etc.) and livestock (32.3%; cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families: - antibiotics; - anti-inflammatories; - cardiology and nephrology treatments; - other: anti-parasitics, vaccines, and nutritional products. At the end of 2022, the group had 5 production sites throughout the world. Net sales are distributed geographically as follows: Europe (46.7%), the Americas (36%) and Asia/Pacific (17.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
99.9 EUR
Average target price
107.1 EUR
Spread / Average Target
+7.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Vetoquinol SA - Euronext Paris